Recent advances in targeted therapy for glioblastoma
Authors:
- Shivani MittalSMShivani Mittal
- Shrikant PradhanSPShrikant Pradhan
- Tapasya SrivastavaTSTapasya Srivastava
- 28 June 2015
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 15 (8) , 935-946
Abstract
Glioblastomas are the most common form of brain tumor with a very dismal prognosis. While a standard treatment regimen of surgery followed by chemo/radiotherapy is currently used, this has only marginally improved the survival time of patients with little benefit on tumor recurrence. Although many molecular targets have already been identified and tested in clinical trials, very few are approved for use in clinics. Efforts are ongoing to target newer molecules that could be used for drug development. This review provides up-to-date information on the drugs and their molecular targets, which are currently in different stages of clinical trials. Since multiple signaling pathways are deregulated, it appears that the use of combination drugs along with personalized targeting approach would provide better therapy in the future.Keywords
This publication has 89 references indexed in Scilit:
- Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trialBMC Cancer, 2013
- Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastomaCancer Medicine, 2013
- Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisitedActa Neuropathologica, 2012
- Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastomaNeuro-Oncology, 2010
- Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerNature Reviews Cancer, 2010
- Potential therapeutic implications of cancer stem cells in glioblastomaBiochemical Pharmacology, 2010
- MicroRNA-34a: A Novel Tumor Suppressor in p53-mutant Glioma Cell Line U251Archives of Medical Research, 2010
- Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase InhibitorsJournal of Biological Chemistry, 2009
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003